These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 17363734)

  • 21. CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11.
    Xanthou G; Duchesnes CE; Williams TJ; Pease JE
    Eur J Immunol; 2003 Aug; 33(8):2241-50. PubMed ID: 12884299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome.
    Belperio JA; Keane MP; Burdick MD; Lynch JP; Xue YY; Li K; Ross DJ; Strieter RM
    J Immunol; 2002 Jul; 169(2):1037-49. PubMed ID: 12097412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rat chemokine CXCL11: structure, tissue distribution, function and expression in cardiac transplantation models.
    Mitsuhashi N; Wu GD; Zhu H; Kearns-Jonker M; Cramer DV; Starnes VA; Barr ML
    Mol Cell Biochem; 2007 Feb; 296(1-2):1-9. PubMed ID: 17264982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist.
    Heise CE; Pahuja A; Hudson SC; Mistry MS; Putnam AL; Gross MM; Gottlieb PA; Wade WS; Kiankarimi M; Schwarz D; Crowe P; Zlotnik A; Alleva DG
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1263-71. PubMed ID: 15761110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CXCR3 requires tyrosine sulfation for ligand binding and a second extracellular loop arginine residue for ligand-induced chemotaxis.
    Colvin RA; Campanella GS; Manice LA; Luster AD
    Mol Cell Biol; 2006 Aug; 26(15):5838-49. PubMed ID: 16847335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparin displaces interferon-gamma-inducible chemokines (IP-10, I-TAC, and Mig) sequestered in the vasculature and inhibits the transendothelial migration and arterial recruitment of T cells.
    Ranjbaran H; Wang Y; Manes TD; Yakimov AO; Akhtar S; Kluger MS; Pober JS; Tellides G
    Circulation; 2006 Sep; 114(12):1293-300. PubMed ID: 16940188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family.
    Lambeir AM; Proost P; Durinx C; Bal G; Senten K; Augustyns K; Scharpé S; Van Damme J; De Meester I
    J Biol Chem; 2001 Aug; 276(32):29839-45. PubMed ID: 11390394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of CXCR3 carboxyl terminus and third intracellular loop in receptor-mediated migration, adhesion and internalization in response to CXCL11.
    Dagan-Berger M; Feniger-Barish R; Avniel S; Wald H; Galun E; Grabovsky V; Alon R; Nagler A; Ben-Baruch A; Peled A
    Blood; 2006 May; 107(10):3821-31. PubMed ID: 16368892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The production of CXCR3-agonistic chemokines by synovial fibroblasts from patients with rheumatoid arthritis.
    Ueno A; Yamamura M; Iwahashi M; Okamoto A; Aita T; Ogawa N; Makino H
    Rheumatol Int; 2005 Jun; 25(5):361-7. PubMed ID: 15004722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of G alpha i2 activation by G alpha i3 in CXCR3-mediated signaling.
    Thompson BD; Jin Y; Wu KH; Colvin RA; Luster AD; Birnbaumer L; Wu MX
    J Biol Chem; 2007 Mar; 282(13):9547-9555. PubMed ID: 17289675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of cysteine-X-cysteine motif chemokine ligands 9, 10, and 11, their receptor CXCR3, and their possible role on the recruitment of immune cells at the maternal-conceptus interface in pigs.
    Han J; Gu MJ; Yoo I; Choi Y; Jang H; Kim M; Yun CH; Ka H
    Biol Reprod; 2017 Jul; 97(1):69-80. PubMed ID: 28859287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The chemokines CXCL9, CXCL10, and CXCL11 differentially stimulate G alpha i-independent signaling and actin responses in human intestinal myofibroblasts.
    Kouroumalis A; Nibbs RJ; Aptel H; Wright KL; Kolios G; Ward SG
    J Immunol; 2005 Oct; 175(8):5403-11. PubMed ID: 16210647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NMR structure of CXCR3 binding chemokine CXCL11 (ITAC).
    Booth V; Clark-Lewis I; Sykes BD
    Protein Sci; 2004 Aug; 13(8):2022-8. PubMed ID: 15273303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matrix metalloproteinase processing of CXCL11/I-TAC results in loss of chemoattractant activity and altered glycosaminoglycan binding.
    Cox JH; Dean RA; Roberts CR; Overall CM
    J Biol Chem; 2008 Jul; 283(28):19389-99. PubMed ID: 18411283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Airway smooth muscle CXCR3 ligand production: regulation by JAK-STAT1 and intracellular Ca²⁺.
    Tan X; Alrashdan YA; Alkhouri H; Oliver BG; Armour CL; Hughes JM
    Am J Physiol Lung Cell Mol Physiol; 2013 Jun; 304(11):L790-802. PubMed ID: 23564506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity.
    Romagnani P; Annunziato F; Lasagni L; Lazzeri E; Beltrame C; Francalanci M; Uguccioni M; Galli G; Cosmi L; Maurenzig L; Baggiolini M; Maggi E; Romagnani S; Serio M
    J Clin Invest; 2001 Jan; 107(1):53-63. PubMed ID: 11134180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function.
    Colvin RA; Campanella GS; Sun J; Luster AD
    J Biol Chem; 2004 Jul; 279(29):30219-27. PubMed ID: 15150261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXCR3/CXCR3 ligand biological axis impairs RENCA tumor growth by a mechanism of immunoangiostasis.
    Pan J; Burdick MD; Belperio JA; Xue YY; Gerard C; Sharma S; Dubinett SM; Strieter RM
    J Immunol; 2006 Feb; 176(3):1456-64. PubMed ID: 16424173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. I-TAC/CXCL11 is a natural antagonist for CCR5.
    Petkovic V; Moghini C; Paoletti S; Uguccioni M; Gerber B
    J Leukoc Biol; 2004 Sep; 76(3):701-8. PubMed ID: 15178708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development.
    Burns JM; Summers BC; Wang Y; Melikian A; Berahovich R; Miao Z; Penfold ME; Sunshine MJ; Littman DR; Kuo CJ; Wei K; McMaster BE; Wright K; Howard MC; Schall TJ
    J Exp Med; 2006 Sep; 203(9):2201-13. PubMed ID: 16940167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.